Ionis Pharmaceuticals, Inc. (0JDI.L)

USD 37.31

(-0.8%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 2.99 Billion 2.53 Billion 2.61 Billion 2.39 Billion 3.23 Billion 2.66 Billion
Total Current Assets 2.64 Billion 2.2 Billion 2.34 Billion 2.13 Billion 2.72 Billion 2.2 Billion
Cash And Short Term Investments 2.33 Billion 1.98 Billion 2.11 Billion 1.89 Billion 2.5 Billion 2.08 Billion
Cash and Cash Equivalents 399.26 Million 1.98 Billion 2.11 Billion 1.89 Billion 2.5 Billion 2.08 Billion
Short Term Investments 1.93 Billion 1.71 Billion 1.24 Billion 1.49 Billion 1.81 Billion 1.8 Billion
Net Receivables 97.77 Million 26 Million 62 Million 76 Million 63 Million 12.75 Million
Inventory 28.42 Million 22.03 Million 24.8 Million 21.96 Million 18.18 Million 8.58 Million
Other Current Assets 184.44 Million 190 Million 168 Million 162 Million 158 Million 111.05 Million
Total Non-Current Assets 348.21 Million 331 Million 267 Million 260 Million 512 Million 459.89 Million
Net PPE 242.93 Million 256 Million 178 Million 181 Million 154 Million 132.16 Million
Good Will And Intangible Assets - - 29 Million 27.93 Million 25.67 Million 24.03 Million
Good Will - - - - - -
Intangible Assets - - 29 Million 27.93 Million 25.67 Million 24.03 Million
Long-Term Investments 42.99 Million 40.37 Million 15.61 Million 15.06 Million -331.23 Million -314.82 Million
Tax Assets - - -15.61 Million -15.06 Million 305.55 Million 290.79 Million
Other Non Current Assets 62.28 Million 34.62 Million 59.99 Million 51.06 Million 358 Million 327.73 Million
Other Assets - - - - - -
Total Liabilities 2.6 Billion 1.96 Billion 1.84 Billion 1.54 Billion 1.54 Billion 1.48 Billion
Total Current Liabilities 448.09 Million 312 Million 241 Million 290 Million 273 Million 280.29 Million
Account Payables 26.02 Million 17.92 Million 11.9 Million 17.19 Million 16.06 Million 28.66 Million
Tax Payables 2.15 Million 6.24 Million 36 Thousand 1.32 Million 32.51 Million -
Short Term Debt 53.16 Million 7.53 Million 3.52 Million 293.16 Million 2.02 Million 13.74 Million
Deferred Revenue 151.12 Million 91 Million 98 Million 108 Million 118 Million 160.25 Million
Other Current Liabilities 217.77 Million 195.54 Million 127.57 Million -128.36 Million 136.9 Million 77.62 Million
Total Non Current Liabilities 2.15 Billion 1.64 Billion 1.59 Billion 1.25 Billion 1.27 Billion 1.2 Billion
Long-Term Debt 1.4 Billion 1.34 Billion 1.16 Billion 749 Million 710 Million 568.21 Million
Deferred Revenue Non Current 241.18 Million 288 Million 352 Million 424 Million 490 Million 567.35 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 513.73 Million 16 Million 86 Million 84 Million 75 Million 64.75 Million
Other Liabilities - - - - - -
Total Equity 386.68 Million 573 Million 772 Million 843 Million 1.68 Billion 1.18 Billion
Stock Holders Equity 386.68 Million 573 Million 772 Million 843 Million 1.47 Billion 1.04 Billion
Common Stock 144 Thousand 142 Thousand 141 Thousand 140 Thousand 140 Thousand 138 Thousand
Retained Earnings -1.79 Billion -1.42 Billion -1.15 Billion -1.24 Billion -707.53 Million -967.29 Million
Accumulated other comprehensive income -32.64 Million -57.48 Million -32.66 Million -21.07 Million -25.29 Million -32.01 Million
Common Stock Equity 386.68 Million 573 Million 772 Million 843 Million 1.47 Billion 1.04 Billion
Capital Lease Obligation 170.87 Million 178 Million 26.37 Million 23.4 Billion 15.54 Million 4.91 Million
Total Investments 1.98 Billion 1.71 Billion 1.24 Billion 1.49 Billion 1.81 Billion 1.8 Billion
Total Debt 1.45 Billion 1.34 Billion 1.16 Billion 749 Million 710 Million 568.21 Million
Net Debt 1.05 Billion -642 Million -954 Million -1.14 Billion -1.79 Billion -1.51 Billion

Balance Sheet Charts